338 related articles for article (PubMed ID: 27572252)
1. FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum.
Reuter MS; Riess A; Moog U; Briggs TA; Chandler KE; Rauch A; Stampfer M; Steindl K; Gläser D; Joset P; ; Krumbiegel M; Rabe H; Schulte-Mattler U; Bauer P; Beck-Wödl S; Kohlhase J; Reis A; Zweier C
J Med Genet; 2017 Jan; 54(1):64-72. PubMed ID: 27572252
[TBL] [Abstract][Full Text] [Related]
2. 7q31.2q31.31 deletion downstream of FOXP2 segregating in a family with speech and language disorder.
Rieger M; Krumbiegel M; Reuter MS; Schützenberger A; Reis A; Zweier C
Am J Med Genet A; 2020 Nov; 182(11):2737-2741. PubMed ID: 32885567
[TBL] [Abstract][Full Text] [Related]
3. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits.
MacDermot KD; Bonora E; Sykes N; Coupe AM; Lai CS; Vernes SC; Vargha-Khadem F; McKenzie F; Smith RL; Monaco AP; Fisher SE
Am J Hum Genet; 2005 Jun; 76(6):1074-80. PubMed ID: 15877281
[TBL] [Abstract][Full Text] [Related]
4. Small intragenic deletion in FOXP2 associated with childhood apraxia of speech and dysarthria.
Turner SJ; Hildebrand MS; Block S; Damiano J; Fahey M; Reilly S; Bahlo M; Scheffer IE; Morgan AT
Am J Med Genet A; 2013 Sep; 161A(9):2321-6. PubMed ID: 23918746
[TBL] [Abstract][Full Text] [Related]
5. Early neuroimaging markers of FOXP2 intragenic deletion.
Liégeois FJ; Hildebrand MS; Bonthrone A; Turner SJ; Scheffer IE; Bahlo M; Connelly A; Morgan AT
Sci Rep; 2016 Oct; 6():35192. PubMed ID: 27734906
[TBL] [Abstract][Full Text] [Related]
6. In-depth characterisation of a cohort of individuals with missense and loss-of-function variants disrupting
Morison LD; Meffert E; Stampfer M; Steiner-Wilke I; Vollmer B; Schulze K; Briggs T; Braden R; Vogel A; Thompson-Lake D; Patel C; Blair E; Goel H; Turner S; Moog U; Riess A; Liegeois F; Koolen DA; Amor DJ; Kleefstra T; Fisher SE; Zweier C; Morgan AT
J Med Genet; 2023 Jun; 60(6):597-607. PubMed ID: 36328423
[TBL] [Abstract][Full Text] [Related]
7. A forkhead-domain gene is mutated in a severe speech and language disorder.
Lai CS; Fisher SE; Hurst JA; Vargha-Khadem F; Monaco AP
Nature; 2001 Oct; 413(6855):519-23. PubMed ID: 11586359
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
[TBL] [Abstract][Full Text] [Related]
9. Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits.
Horn D; Kapeller J; Rivera-Brugués N; Moog U; Lorenz-Depiereux B; Eck S; Hempel M; Wagenstaller J; Gawthrope A; Monaco AP; Bonin M; Riess O; Wohlleber E; Illig T; Bezzina CR; Franke A; Spranger S; Villavicencio-Lorini P; Seifert W; Rosenfeld J; Klopocki E; Rappold GA; Strom TM
Hum Mutat; 2010 Nov; 31(11):E1851-60. PubMed ID: 20848658
[TBL] [Abstract][Full Text] [Related]
10. Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review.
Lennon PA; Cooper ML; Peiffer DA; Gunderson KL; Patel A; Peters S; Cheung SW; Bacino CA
Am J Med Genet A; 2007 Apr; 143A(8):791-8. PubMed ID: 17330859
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the genetic basis of speech and language disorders.
Fisher SE; Lai CS; Monaco AP
Annu Rev Neurosci; 2003; 26():57-80. PubMed ID: 12524432
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Expressive Speech Disorder in a Family as a Hallmark of 7q31 Deletion Involving the
Nagy O; Kárteszi J; Elmont B; Ujfalusi A
Front Pediatr; 2021; 9():664548. PubMed ID: 34490154
[TBL] [Abstract][Full Text] [Related]
13. Phenotype of FOXP2 haploinsufficiency in a mother and son.
Rice GM; Raca G; Jakielski KJ; Laffin JJ; Iyama-Kurtycz CM; Hartley SL; Sprague RE; Heintzelman AT; Shriberg LD
Am J Med Genet A; 2012 Jan; 158A(1):174-81. PubMed ID: 22106036
[TBL] [Abstract][Full Text] [Related]
14. Genetics of speech and language disorders.
Kang C; Drayna D
Annu Rev Genomics Hum Genet; 2011; 12():145-64. PubMed ID: 21663442
[TBL] [Abstract][Full Text] [Related]
15. Equivalent missense variant in the FOXP2 and FOXP1 transcription factors causes distinct neurodevelopmental disorders.
Sollis E; Deriziotis P; Saitsu H; Miyake N; Matsumoto N; Hoffer MJV; Ruivenkamp CAL; Alders M; Okamoto N; Bijlsma EK; Plomp AS; Fisher SE
Hum Mutat; 2017 Nov; 38(11):1542-1554. PubMed ID: 28741757
[TBL] [Abstract][Full Text] [Related]
16. High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders.
Vernes SC; Spiteri E; Nicod J; Groszer M; Taylor JM; Davies KE; Geschwind DH; Fisher SE
Am J Hum Genet; 2007 Dec; 81(6):1232-50. PubMed ID: 17999362
[TBL] [Abstract][Full Text] [Related]
17. Developmental disorders of speech and language: from genes to brain structure and function.
Watkins K
Prog Brain Res; 2011; 189():225-38. PubMed ID: 21489392
[TBL] [Abstract][Full Text] [Related]
18. Genetic advances in the study of speech and language disorders.
Newbury DF; Monaco AP
Neuron; 2010 Oct; 68(2):309-20. PubMed ID: 20955937
[TBL] [Abstract][Full Text] [Related]
19. FOXP2 as a molecular window into speech and language.
Fisher SE; Scharff C
Trends Genet; 2009 Apr; 25(4):166-77. PubMed ID: 19304338
[TBL] [Abstract][Full Text] [Related]
20. Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex.
Roll P; Vernes SC; Bruneau N; Cillario J; Ponsole-Lenfant M; Massacrier A; Rudolf G; Khalife M; Hirsch E; Fisher SE; Szepetowski P
Hum Mol Genet; 2010 Dec; 19(24):4848-60. PubMed ID: 20858596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
